A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma
Keywords: Bladder cancer; urothelial carcinoma; uroplakin II; GATA-3; p40; ÎNp63; immunohistochemistry; survival;